Literature DB >> 12736483

Characteristics and 1-year prognosis of medically treated patients with chronic heart failure in Japan.

Yoshito Koseki1, Jun Watanabe, Tsuyoshi Shinozaki, Masahito Sakuma, Tatsuya Komaru, Mitsumasa Fukuchi, Masahito Miura, Akihiko Karibe, Yuji Kon-No, Hirotaka Numaguchi, Mototsugu Ninomiya, Yutaka Kagaya, Kunio Shirato.   

Abstract

The study was designed to characterize patients with chronic heart failure (CHF) in Japan in terms of the etiologies and prognosis. CHF was defined by ejection fraction (EF >or=50%), left ventricular diastolic dimension (LVDD >or=55 mm) or a past history of congestive heart failure. Among the 721 recruited patients, the most frequent etiology for CHF was dilated cardiomyopathy (DCM) in patients aged less than 59 years, and valvular heart disease (VHD) in those aged 70 years or more. The 1-year crude mortality was 8% overall and 12% in patients with myocardial infarction (MI). Sudden death accounted for 40% of the total deaths among all patients, and 60% in patients with MI. Multivariate logistic regression analysis showed that brain natriuretic peptide (BNP) was a consistent prognostic marker in CHF patients with a variety of etiologies. Total death and hospitalization because of heart failure were significantly less frequent in patients with BNP less than 100 pg/ml. In conclusion, the etiologies of Japanese CHF appear to be more diverse than those of other Western countries, but BNP is an excellent prognostic marker despite the etiological diversity. Sudden, unexpected death in CHF patients is also a serious problem in Japan. A nation-wide epidemiologic study should be done to characterize Japanese CHF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736483     DOI: 10.1253/circj.67.431

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

Review 1.  The paradox of low BNP levels in obesity.

Authors:  Aldo Clerico; Alberto Giannoni; Simona Vittorini; Michele Emdin
Journal:  Heart Fail Rev       Date:  2012-01       Impact factor: 4.214

2.  Kyoto Congestive Heart Failure (KCHF) study: rationale and design.

Authors:  Erika Yamamoto; Takao Kato; Neiko Ozasa; Hidenori Yaku; Yasutaka Inuzuka; Yodo Tamaki; Takeshi Kitai; Takeshi Morimoto; Ryoji Taniguchi; Moritake Iguchi; Masashi Kato; Mamoru Takahashi; Toshikazu Jinnai; Tomoyuki Ikeda; Kazuya Nagao; Takafumi Kawai; Akihiro Komasa; Ryusuke Nishikawa; Yuichi Kawase; Takashi Morinaga; Tsuneaki Kawashima; Yasuyo Motohashi; Mitsunori Kawato; Mamoru Toyofuku; Yukihito Sato; Koichiro Kuwahara; Tetsuo Shioi; Takeshi Kimura
Journal:  ESC Heart Fail       Date:  2017-02-17

3.  Natriuretic Peptide testing in primary care.

Authors:  Shafiq U Rehman; James L Januzzi
Journal:  Curr Cardiol Rev       Date:  2008-11

Review 4.  Heart failure in East Asia.

Authors:  Yutao Guo; Gregory Y H Lip; Amitava Banerjee
Journal:  Curr Cardiol Rev       Date:  2013-05

5.  Secular trends in the etiology and comorbidity of hospitalized patients with congestive heart failure: A single-center retrospective study.

Authors:  Zhi-Yong Pei; Yu-Sheng Zhao; Jia-Yue Li; Qiao Xue; Lei Gao; Shi-Wen Wang
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

6.  Survival of patients with chronic heart failure in the community: a systematic review and meta-analysis.

Authors:  Nicholas R Jones; Andrea K Roalfe; Ibiye Adoki; F D Richard Hobbs; Clare J Taylor
Journal:  Eur J Heart Fail       Date:  2019-09-16       Impact factor: 15.534

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.